Background:Hypertension continues to be a major causative factor contributing to cardiovascular, cerebrovascular and renal morbidity and mortality.Aim:The objective of this study was to assess the prevalence, awareness and control of hypertension in the estate population in Johor, Malaysia.Patients and Methods:A mercury sphygmomanometer was used to record systolic and diastolic blood pressures. Cross sectional population survey was carried out in the study.Results:The overall prevalence of hypertension in 903 subjects studied was 26.91% (243). A higher prevalence 27.65 % (133) was found in males against 26.07% (110) in females. Awareness of the disease was present in only 39% (96) of which 86.45% (83) received treatment. Among those who received treatment, control of hypertension was present in 15.66% (13).Conclusion:The prevalence of hypertension among the estate population is lower than that of the general population of Malaysia, which can be attributed to their regular physical activity but the awareness, treatment, control and follow-up of patients is disappointingly low.
Background: Albeit not life-threatening, symptoms of irritable bowel syndrome (IBS) interfere with routine activities and compromise the quality of life (QOL). Except for one survey on the prevalence of IBS among students in Malaysia a decade back, there are no other reports. QOL in IBS is yet to be investigated in this region. Objective: To determine the prevalence of IBS and its impact on QOL among students at a Malaysian medical university. Methodology: A cross-sectional, questionnaire-based, self-reported study was conducted among
Original Research Article
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.